Literature DB >> 24862997

Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth disease.

A Colling1, C Morrissy, J Barr, G Meehan, L Wright, W Goff, L J Gleeson, B van der Heide, S Riddell, M Yu, D Eagles, R Lunt, S Khounsy, N G O Than Long, Pham Phong Vu, Nguyen Than Phuong, Nguyen Tung, W Linchongsubongkoch, J Hammond, M Johnson, W O Johnson, H Unger, P Daniels, J R Crowther.   

Abstract

OBJECTIVE: To measure the diagnostic performance of an Australian-developed ELISA for the detection of antibodies against the non-structural proteins (NSP) 3ABC of the foot and mouth disease (FMD) virus.
DESIGN: Test development and validation study.
METHODS: The diagnostic specificity was determined using 2535 sera from naïve animals and 1112 sera from vaccinated animals. Diagnostic sensitivity was calculated from the data for 995 sera from experimentally and field-infected animals from FMD-endemic countries in South East Asia. A commercial ELISA detecting antibodies against FMD virus NSP was used as the reference test to establish relative sensitivity and specificity. Bayesian latent class analysis was performed to corroborate results. The diagnostic window and rate of detection were determined at different times using sera from cattle, sheep and pigs before and after infection, and after vaccination and subsequent infection. Repeatability and reproducibility data were established.
RESULTS: At 35% test cut-off, the 3ABC ELISA had an overall diagnostic sensitivity of 91.5% and diagnostic specificity of 96.4%. The diagnostic sensitivity in vaccinated and subsequently infected cattle was 68.4% and diagnostic specificity in vaccinated cattle was 98.0%.
CONCLUSIONS: The 3ABC ELISA identified field and experimentally infected animals, as well as vaccinated and subsequently infected animals. Diagnostic sensitivity and specificity estimates for other FMD NSP tests are comparable with the results obtained in this study. This NSP ELISA was found to be 'fit for purpose' as a screening assay at the herd level to detect viral infection and also to substantiate absence of infection.
© 2014 Australian Veterinary Association.

Entities:  

Keywords:  3ABC ELISA; foot and mouth disease; screening tests

Mesh:

Substances:

Year:  2014        PMID: 24862997     DOI: 10.1111/avj.12190

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  3 in total

1.  Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B.

Authors:  Alyssa K Van Dreumel; Wojtek P Michalski; Leanne M McNabb; Brian J Shiell; Nagendrakumar B Singanallur; Grantley R Peck
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

2.  Evaluation of six serological ELISA kits available in Italy as screening tests for equine infectious anaemia surveillance.

Authors:  Roberto Nardini; Gian Luca Autorino; Charles J Issel; R Frank Cook; Ida Ricci; Raffaele Frontoso; Francesca Rosone; Maria Teresa Scicluna
Journal:  BMC Vet Res       Date:  2017-04-14       Impact factor: 2.741

3.  The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle.

Authors:  Sigal Gelkop; Ariel Sobarzo; Polina Brangel; Cécile Vincke; Ema Romão; Shlomit Fedida-Metula; Nick Strom; Irene Ataliba; Frank Norbet Mwiine; Sylvester Ochwo; Lauro Velazquez-Salinas; Rachel A McKendry; Serge Muyldermans; Julius Julian Lutwama; Elizabeth Rieder; Victoria Yavelsky; Leslie Lobel
Journal:  Front Vet Sci       Date:  2018-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.